Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS) Sees Large Increase in Short Interest

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS - Get Free Report) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 3,640,000 shares, an increase of 23.0% from the April 30th total of 2,960,000 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is presently 3.1 days.

Institutional Trading of Companhia de Saneamento Básico do Estado de São Paulo - SABESP

Institutional investors and hedge funds have recently bought and sold shares of the stock. Amundi boosted its position in shares of Companhia de Saneamento Básico do Estado de São Paulo - SABESP by 6.7% in the fourth quarter. Amundi now owns 6,752,801 shares of the utilities provider's stock valued at $96,732,000 after acquiring an additional 426,669 shares during the period. Deutsche Bank AG lifted its holdings in shares of Companhia de Saneamento Básico do Estado de São Paulo - SABESP by 55.1% in the fourth quarter. Deutsche Bank AG now owns 6,234,236 shares of the utilities provider's stock worth $89,337,000 after acquiring an additional 2,213,846 shares during the last quarter. Citigroup Inc. boosted its stake in shares of Companhia de Saneamento Básico do Estado de São Paulo - SABESP by 50.6% in the 1st quarter. Citigroup Inc. now owns 2,473,310 shares of the utilities provider's stock valued at $44,173,000 after purchasing an additional 830,937 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of Companhia de Saneamento Básico do Estado de São Paulo - SABESP by 2.0% in the 4th quarter. Renaissance Technologies LLC now owns 1,730,495 shares of the utilities provider's stock valued at $24,798,000 after purchasing an additional 33,200 shares in the last quarter. Finally, Strs Ohio bought a new stake in shares of Companhia de Saneamento Básico do Estado de São Paulo - SABESP during the 1st quarter valued at approximately $29,142,000. Institutional investors own 10.62% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded Companhia de Saneamento Básico do Estado de São Paulo - SABESP from a "buy" rating to a "hold" rating in a research report on Tuesday, May 20th.

Companhia de Saneamento Básico do Estado de São Paulo - SABESP Stock Down 0.3%

Shares of SBS stock traded down $0.06 during trading on Friday, reaching $20.50. The company's stock had a trading volume of 962,119 shares, compared to its average volume of 1,113,176. Companhia de Saneamento Básico do Estado de São Paulo - SABESP has a one year low of $13.10 and a one year high of $21.14. The business has a fifty day moving average price of $19.60 and a 200-day moving average price of $17.25. The company has a market cap of $14.01 billion, a price-to-earnings ratio of 8.07 and a beta of 0.72. The company has a quick ratio of 1.13, a current ratio of 1.14 and a debt-to-equity ratio of 0.56.

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The utilities provider reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $0.38 by ($0.01). The business had revenue of $1.04 billion for the quarter, compared to analyst estimates of $7.67 billion. Companhia de Saneamento Básico do Estado de São Paulo - SABESP had a return on equity of 27.73% and a net margin of 25.62%. Analysts anticipate that Companhia de Saneamento Básico do Estado de São Paulo - SABESP will post 2.17 earnings per share for the current year.

Companhia de Saneamento Básico do Estado de São Paulo - SABESP Company Profile

Companhia de Saneamento Basico do Estado de Sao Paulo SABESP engages in the provision of water and sewage service. It also offers advisory services on the rational use of water, planning and commercial, and financial and operational management. The company was founded on September 6, 1973 and is headquartered in São Paulo, Brazil.